Search for: "US v. John Anderson" Results 481 - 500 of 522
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Nov 2008, 1:36 pm
(IPKat) EU favours disclosure of computer patents before standards are set (Intellectual Property Watch) Trade Marks Court of First Instance finds RAUTARUUKKI fails to satisfy acquired distinctiveness criterion: Rautaruukki Oyj v OHIM (Class 46) Court of First Instance finds original signature of famous Italian lutist Antonio Stradivari, in arte Stradivarius, of the 17th century, cannot be read by relevant consumers: T‑340/06 (Catch Us If You Can!!!) [read post]
30 Sep 2008, 9:18 am
He was assisted by V&E’s Bruce Blefeld, James Reeder Jr. and Harry Reasoner. [read post]
22 Sep 2008, 11:00 am
Anderson took a different spin on the "Making Book" article in the November 2007 issue of DRI's For The Defense. [read post]
18 Sep 2008, 8:56 pm
Opinion below (9th Circuit) Petition for certiorari Brief in opposition Petitioner’s reply __________________ Docket: 07-1370 Case name: Long John Silver’s, Inc. v. [read post]
18 Jul 2008, 10:28 am
AndersonCitation: 2008 WY 80Docket Number: S-07-0138Appeal from the District Court of Goshen County, Honorable John C. [read post]
6 Jun 2008, 3:41 pm
Similarly, the petition in Anderson v. [read post]
5 Jun 2008, 2:05 am
Anderson    Eastern District of Tennessee of Chattanooga 08a0199p.062008/05/27 Zaluski v. [read post]
5 Jun 2008, 2:05 am
Anderson    Eastern District of Tennessee of Chattanooga 08a0199p.062008/05/27 Zaluski v. [read post]
4 Jun 2008, 3:28 am
In each, actual traffic stops using the SFSTs were investigated. [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva… [read post]